Corbus Pharmaceuticals Holdings (CRBP) Cash from Operations (QoQ) (2014 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Cash from Operations (QoQ) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.73 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.60 Bn | 467.81 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.34 Bn | 115.09 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.14 Bn | 61.39 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.79 Bn | 62.79 Bn | - |
| 8 | Argenx Se | 56.19 Bn | 51.00 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn |
| 10 | Corbus Pharmaceuticals Holdings | 114.33 Mn | 86.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 6.32% |
| Jun 30, 2025 | -1.08% |
| Mar 31, 2025 | -50.07% |
| Dec 31, 2024 | 21.52% |
| Sep 30, 2024 | -55.90% |
| Jun 30, 2024 | -12.25% |
| Mar 31, 2024 | -32.61% |
| Dec 31, 2023 | 16.28% |
| Sep 30, 2023 | 8.01% |
| Jun 30, 2023 | 48.39% |
| Mar 31, 2023 | -102.75% |
| Dec 31, 2022 | -2.90% |
| Sep 30, 2022 | 40.76% |
| Jun 30, 2022 | -15.20% |
| Mar 31, 2022 | -9.41% |
| Dec 31, 2021 | -1,232.22% |
| Sep 30, 2021 | 104.89% |
| Jun 30, 2021 | 19.63% |
| Mar 31, 2021 | -19.67% |
| Dec 31, 2020 | 33.13% |